生物
抗体
计算生物学
病毒学
任务(项目管理)
过程(计算)
病毒
人工智能
计算机科学
抗体库
人流感
机制(生物学)
抗体反应
免疫学
变量(数学)
表位
作者
Perry T. Wasdin,Nicole V. Johnson,Alexis K. Janke,Sofia Held,Toma M. Marinov,Gwen Jordaan,Rebecca A. Gillespie,Léna Vandenabeele,Fani Pantouli,Olivia C. Powers,Matthew J. Vukovich,Clinton Holt,Jeong-Ryeol Kim,Grant S. Hansman,Jennifer K. Logue,Helen Y. Chu,Sarah F. Andrews,Masaru Kanekiyo,Giuseppe Andrea Sautto,Ted M. Ross
出处
期刊:Cell
[Cell Press]
日期:2025-11-04
卷期号:188 (25): 7206-7221.e16
被引量:44
标识
DOI:10.1016/j.cell.2025.10.006
摘要
The traditional process of antibody discovery is limited by inefficiency, high costs, and low success rates. Recent approaches employing artificial intelligence (AI) have been developed to optimize existing antibodies and generate antibody sequences in a target-agnostic manner. In this work, we present MAGE (monoclonal antibody generator), a sequence-based protein language model (PLM) fine-tuned for the task of generating paired human variable heavy- and light-chain antibody sequences against targets of interest. We show that MAGE can generate novel and diverse antibody sequences with experimentally validated binding specificity against SARS-CoV-2, an emerging avian influenza H5N1, and respiratory syncytial virus A (RSV-A). MAGE represents a first-in-class model capable of designing human antibodies against multiple targets with no starting template.
科研通智能强力驱动
Strongly Powered by AbleSci AI